Myla Goldman
University of Virginia
H-index: 34
North America-United States
Top articles of Myla Goldman
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Multiple Sclerosis and Family Planning: A Survey Study of the Patient Experience | Neurology: Clinical Practice | Erin E Kelly Casey Engel Rylan Pearsall J Nicholas Brenton Riley Bove | 2024/2 |
A 42-Year-Old Woman With Rapidly Expanding White Matter Lesions: From the National Multiple Sclerosis Society Case Conference Proceedings | Neurology: Neuroimmunology & Neuroinflammation | Tolulope O Amiola Unsong Oh Hope Richard Scott D Newsome Jennifer Graves | 2024/1/29 |
Trends in Management Practices of Seropositive Neuromyelitis Optica Spectrum Disorder: Lessons from a Multicenter Academic Cohort (P10-14.010) | Leah Zuroff Jaeleene Wijangco Rachel Brandstadter Myla Goldman Edith Graham | 2024/4/14 | |
Serum neurofilament light chain in relapsing multiple sclerosis patients on a ketogenic diet | Multiple Sclerosis and Related Disorders | Unsong Oh Emma Woolbright Diana Lehner-Gulotta Rachael Coleman Mark Conaway | 2023/5/1 |
Multiple Sclerosis & Family Planning: Patient Experience (P9-3.006) | Erin Kelly Casey Engel Rylan Pearsall Myla Goldman | 2023/4/25 | |
Ketogenic Diet Intervention Improves Sleep in Patients with Relapsing Multiple Sclerosis (P8-3.009) | Jacob Perlman Diana Lehner-Gulotta Emma Wetmore Rachael Coleman Brenda Banwell | 2023/4/25 | |
Progression risk stratification with six-minute walk gait speed trajectory in multiple sclerosis | Frontiers in Neurology | Myla D Goldman Shanshan Chen Robert Motl Rylan Pearsall Unsong Oh | 2023/10/4 |
Ketogenic diet in relapsing multiple sclerosis: Patient perceptions, post-trial diet adherence & outcomes | Clinical Nutrition | Emma Wetmore Diana Lehner-Gulotta Brian Florenzo Brenda Banwell AG Christina Bergqvist | 2023/8/1 |
Gender disparities in the career of neurology researchers | Neurology | Deborah A Hall Carolyn Cahill Ana-Claire L Meyer Amanda Peltier Marisela Dy-Hollins | 2023/1/31 |
Multiple sclerosis progression: time for a new mechanism-driven framework | Tanja Kuhlmann Marcello Moccia Timothy Coetzee Jeffrey A Cohen Jorge Correale | 2023/1/1 | |
Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind … | The Lancet Neurology | John R Corboy Robert J Fox Ilya Kister Gary R Cutter Charity J Morgan | 2023/7/1 |
Gender Disparities in Neurology Research (S34. 002) | Deborah Hall Carolyn Cahill Ana-Claire Meyer Amanda Peltier Marisela Dy-Hollins | 2022/5/3 | |
Six-minute walk as a measure of walking capacity and endurance in patients with pediatric-onset multiple sclerosis | Neurology | J Nicholas Brenton Brian Florenzo Hitoshi Koshiya Seulgi Min Emma Woolbright | 2022/11/8 |
Ketogenic Diet as a Strategy for Improved Wellness and Reduced Disability in Relapsing Multiple Sclerosis (S40. 007) | J Nicholas Brenton Diana Lehner-Gulotta Emma Woolbright Rachael Coleman Mark Conaway | 2022/5/3 | |
Multiple Sclerosis and Related Disorders | Gro O Nygaard Sigrid A de Rodez Benavent Hanne F Harbo Bruno Laeng Piotr Sowa | 2015/8/11 | |
Treatment of Multiple Sclerosis | Nutrition and Lifestyle in Neurological Autoimmune Diseases: Multiple Sclerosis | C COSTANTINO O LICARI A CARTER L HUMPHREYS B SHARRACK | 2016/12/23 |
A Phase 3, double-blind, placebo-controlled efficacy and safety study of ADS-5102 (Amantadine) extended-release capsules in people with multiple sclerosis and walking impairment | Multiple Sclerosis Journal | Jeffrey A Cohen Michelle H Cameron Myla D Goldman Andrew D Goodman Aaron E Miller | 2022/4 |
Epidemiology and pathophysiology of multiple sclerosis | Melanie Ward Myla D Goldman | 2022/8/1 | |
Relationship between balance confidence and social engagement in people with multiple sclerosis | Multiple sclerosis and related disorders | Grace I Judd Andrea D Hildebrand Myla D Goldman Michelle H Cameron | 2022/1/1 |
Phase II study of ketogenic diets in relapsing multiple sclerosis: safety, tolerability and potential clinical benefits | Journal of Neurology, Neurosurgery & Psychiatry | J Nicholas Brenton Diana Lehner-Gulotta Emma Woolbright Brenda Banwell AG Christina Bergqvist | 2022/6/1 |
